Valid for Submission
C78.89 is a billable code used to specify a medical diagnosis of secondary malignant neoplasm of other digestive organs. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C78.89 might also be used to specify conditions or terms like ampulla of vater tnm finding, extrahepatic bile ducts tnm finding, hypopharyngeal tnm finding, lymphoma finding, lymphoma involves spleen, malignant melanoma metastatic to pancreas, etc
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: ampulla of Vater ; antrum (Highmore) (maxillary) pyloric ; bile or biliary (tract) ; bile or biliary (tract) canals, interlobular ; bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) ; bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) interlobular ; bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) intrahepatic and extrahepatic ; etc
| ICD-10: | C78.89 |
| Short Description: | Secondary malignant neoplasm of other digestive organs |
| Long Description: | Secondary malignant neoplasm of other digestive organs |
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C78.89:
Code Also
Code AlsoA "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- exocrine pancreatic insufficiency K86.81
Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Ampulla of Vater TNM finding
- Extrahepatic bile ducts TNM finding
- Hypopharyngeal TNM finding
- Lymphoma finding
- Lymphoma involves spleen
- Malignant melanoma metastatic to pancreas
- Malignant neoplasm of cardio-esophageal junction of stomach
- Malignant tumor of ampulla of Vater
- Malignant tumor of body of pancreas
- Malignant tumor of body of stomach
- Malignant tumor of cervical part of esophagus
- Malignant tumor of endocrine pancreas
- Malignant tumor of fundus of stomach
- Malignant tumor of gallbladder
- Malignant tumor of greater curve of stomach
- Malignant tumor of head of pancreas
- Malignant tumor of lesser curve of stomach
- Malignant tumor of middle third of esophagus
- Malignant tumor of pancreatic duct
- Malignant tumor of pancreatic duct
- Malignant tumor of pyloric antrum
- Malignant tumor of pylorus
- Malignant tumor of tail of pancreas
- Malignant tumor of thoracic part of esophagus
- Malignant tumor of tonsillar fossa
- Malignant tumor of upper third of esophagus
- Metastasis to pancreas of unknown primary
- Metastasis to spleen of unknown primary
- Metastatic HER2 positive gastroesophageal junction cancer
- Metastatic malignant melanoma
- Neoplasm of body of pancreas
- Neoplasm of cervical esophagus
- Neoplasm of cystic duct
- Neoplasm of diaphragm
- Neoplasm of fundus of stomach
- Neoplasm of greater curvature of stomach
- Neoplasm of head of pancreas
- Neoplasm of lesser curvature of stomach
- Neoplasm of middle third of esophagus
- Neoplasm of muscle of thorax
- Neoplasm of pyloric antrum
- Neoplasm of pylorus
- Neoplasm of tail of pancreas
- Neoplasm of thoracic esophagus
- Neoplasm of tonsillar fossa
- Neoplasm of upper third of esophagus
- pT3: Tumor invades pancreas
- pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein
- pT4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus or central compartment of soft tissue
- Pyloric mass
- Secondary carcinoma of gastrointestinal tract
- Secondary malignant neoplasm of abdominal esophagus
- Secondary malignant neoplasm of ampulla of Vater
- Secondary malignant neoplasm of biliary tract
- Secondary malignant neoplasm of body of pancreas
- Secondary malignant neoplasm of body of stomach
- Secondary malignant neoplasm of cardia of stomach
- Secondary malignant neoplasm of cervical esophagus
- Secondary malignant neoplasm of common bile duct
- Secondary malignant neoplasm of cystic duct
- Secondary malignant neoplasm of diaphragm
- Secondary malignant neoplasm of duodenum
- Secondary malignant neoplasm of esophagus
- Secondary malignant neoplasm of extrahepatic bile ducts
- Secondary malignant neoplasm of fundus of stomach
- Secondary malignant neoplasm of gallbladder
- Secondary malignant neoplasm of gastrointestinal tract
- Secondary malignant neoplasm of greater curvature of stomach
- Secondary malignant neoplasm of head of pancreas
- Secondary malignant neoplasm of intestinal tract
- Secondary malignant neoplasm of islets of Langerhans
- Secondary malignant neoplasm of lateral wall of oropharynx
- Secondary malignant neoplasm of lesser curvature of stomach
- Secondary malignant neoplasm of lower third of esophagus
- Secondary malignant neoplasm of middle third of esophagus
- Secondary malignant neoplasm of muscle of abdomen
- Secondary malignant neoplasm of muscle of thorax
- Secondary malignant neoplasm of muscle of trunk
- Secondary malignant neoplasm of pancreas
- Secondary malignant neoplasm of pancreatic duct
- Secondary malignant neoplasm of pyloric antrum
- Secondary malignant neoplasm of pylorus
- Secondary malignant neoplasm of respiratory and digestive systems
- Secondary malignant neoplasm of small intestine
- Secondary malignant neoplasm of spleen
- Secondary malignant neoplasm of stomach
- Secondary malignant neoplasm of tail of pancreas
- Secondary malignant neoplasm of thoracic esophagus
- Secondary malignant neoplasm of tonsil
- Secondary malignant neoplasm of tonsillar fossa
- Secondary malignant neoplasm of upper third of esophagus
- Secondary malignant neoplasm of Waldeyer's ring
- T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, deep base of tongue
- T3: Ampulla tumor invades 2 cm or less into pancreas
- T3: Pancreatic tumor extends directly to any of the following: duodenum; bile duct; peripancreatic tissues
- T4: Aerodigestive tract tumor invades adjacent structures
- T4: Ampulla tumor invades >2 cm into pancreas and/or into other adjacent organs
- T4: Lung tumor of any size that invades any of the following: mediastinum; heart; great vessels; trachea; esophagus; vertebral body; carina
- T4: Pancreas tumor extends directly to any of the following: stomach; spleen; colon; adjacent large vessels
- T4: Tumor invades through cricoid or thyroid cartilage and/or extends into other tissues beyond the larynx
- T4: Tumor invades through thyroid cartilage, and/or extends into soft tissues of the neck, thyroid, and/or esophagus
- Tumor invades beyond pancreatic capsule to adjacent structures AND/OR organs
- Tumor invades beyond pancreatic capsule to adjacent structures AND/OR organs
- Tumor invades beyond pancreatic capsule to adjacent structures AND/OR organs
- Tumor invades beyond pancreatic capsule to bile duct
- Tumor invades beyond pancreatic capsule to spleen
- Tumor invades beyond pancreatic capsule to stomach
Diagnostic Related Groups
The ICD-10 code C78.89 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2019 through 09/30/2020.
- 374 - DIGESTIVE MALIGNANCY WITH MCC
- 375 - DIGESTIVE MALIGNANCY WITH CC
- 376 - DIGESTIVE MALIGNANCY WITHOUT CC/MCC
Convert C78.89 to ICD-9
- 197.8 - Sec mal neo GI NEC (Approximate Flag)
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020